These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 22114827)

  • 1. Anticoagulation-associated adverse drug events.
    Piazza G; Nguyen TN; Cios D; Labreche M; Hohlfelder B; Fanikos J; Fiumara K; Goldhaber SZ
    Am J Med; 2011 Dec; 124(12):1136-42. PubMed ID: 22114827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, preventability, and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study.
    Kunac DL; Kennedy J; Austin N; Reith D
    Paediatr Drugs; 2009; 11(2):153-60. PubMed ID: 19301935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation-Associated Adverse Drug Events in Hospitalized Patients Across Two Time Periods.
    Fanikos J; Tawfik Y; Almheiri D; Sylvester K; Buckley LF; Dew C; Dell'Orfano H; Armero A; Bejjani A; Bikdeli B; Campia U; Davies J; Fiumara K; Hogan H; Khairani CD; Krishnathasan D; Lou J; Makawi A; Morrison RH; Porio N; Tristani A; Connors JM; Goldhaber SZ; Piazza G
    Am J Med; 2023 Sep; 136(9):927-936.e3. PubMed ID: 37247752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse drug events and medication errors in Australia.
    Runciman WB; Roughead EE; Semple SJ; Adams RJ
    Int J Qual Health Care; 2003 Dec; 15 Suppl 1():i49-59. PubMed ID: 14660523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology of adverse drug events and medication errors among psychiatric inpatients in Japan: the JADE study.
    Ayani N; Sakuma M; Morimoto T; Kikuchi T; Watanabe K; Narumoto J; Fukui K
    BMC Psychiatry; 2016 Aug; 16(1):303. PubMed ID: 27577925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventable and non-preventable adverse drug events in hospitalized patients: a prospective chart review in the Netherlands.
    Dequito AB; Mol PG; van Doormaal JE; Zaal RJ; van den Bemt PM; Haaijer-Ruskamp FM; Kosterink JG
    Drug Saf; 2011 Nov; 34(11):1089-100. PubMed ID: 21981436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving drug safety in hospitals: a retrospective study on the potential of adverse drug events coded in routine data.
    Kuklik N; Stausberg J; Amiri M; Jöckel KH
    BMC Health Serv Res; 2019 Aug; 19(1):555. PubMed ID: 31395053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug events caused by medication errors in medical inpatients.
    Hardmeier B; Braunschweig S; Cavallaro M; Roos M; Pauli-Magnus C; Giger M; Meier PJ; Fattinger K
    Swiss Med Wkly; 2004 Nov; 134(45-46):664-70. PubMed ID: 15611888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication errors and adverse drug events in pediatric inpatients.
    Kaushal R; Bates DW; Landrigan C; McKenna KJ; Clapp MD; Federico F; Goldmann DA
    JAMA; 2001 Apr; 285(16):2114-20. PubMed ID: 11311101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detecting medication errors in the New Zealand pharmacovigilance database: a retrospective analysis.
    Kunac DL; Tatley MV
    Drug Saf; 2011 Jan; 34(1):59-71. PubMed ID: 21142271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse drug events in hospitalized cardiac patients.
    Fanikos J; Cina JL; Baroletti S; Fiumara K; Matta L; Goldhaber SZ
    Am J Cardiol; 2007 Nov; 100(9):1465-9. PubMed ID: 17950809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical approach to determining costs and frequency of adverse drug events in a health care network.
    Senst BL; Achusim LE; Genest RP; Cosentino LA; Ford CC; Little JA; Raybon SJ; Bates DW
    Am J Health Syst Pharm; 2001 Jun; 58(12):1126-32. PubMed ID: 11449856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug events and medication errors in Japanese paediatric inpatients: a retrospective cohort study.
    Sakuma M; Ida H; Nakamura T; Ohta Y; Yamamoto K; Seki S; Hiroi K; Kikuchi K; Nakayama K; Bates DW; Morimoto T
    BMJ Qual Saf; 2014 Oct; 23(10):830-7. PubMed ID: 24742779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of adverse drug events and medication errors in intensive care units: a prospective multicenter study.
    Benkirane RR; Abouqal R; Haimeur CC; S Ech Cherif El Kettani SS; Azzouzi AA; Mdaghri Alaoui AA; Thimou AA; Nejmi MM; Maazouzi WW; Madani NN; R-Edwards I; Soulaymani RR
    J Patient Saf; 2009 Mar; 5(1):16-22. PubMed ID: 19920434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care.
    Thomsen LA; Winterstein AG; Søndergaard B; Haugbølle LS; Melander A
    Ann Pharmacother; 2007 Sep; 41(9):1411-26. PubMed ID: 17666582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying clinically significant preventable adverse drug events through a hospital's database of adverse drug reaction reports.
    Winterstein AG; Hatton RC; Gonzalez-Rothi R; Johns TE; Segal R
    Am J Health Syst Pharm; 2002 Sep; 59(18):1742-9. PubMed ID: 12298112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug events in older hospitalized patients: results and reliability of a comprehensive and structured identification strategy.
    Klopotowska JE; Wierenga PC; Stuijt CC; Arisz L; Dijkgraaf MG; Kuks PF; Asscheman H; de Rooij SE; Lie-A-Huen L; Smorenburg SM;
    PLoS One; 2013; 8(8):e71045. PubMed ID: 23940688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The national cost of adverse drug events resulting from inappropriate medication-related alert overrides in the United States.
    Slight SP; Seger DL; Franz C; Wong A; Bates DW
    J Am Med Inform Assoc; 2018 Sep; 25(9):1183-1188. PubMed ID: 29939271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Medicare Administrative Claims to Identify a Population at High Risk for Adverse Drug Events and Hospital Use for Quality Improvement.
    Digmann R; Thomas A; Peppercorn S; Ryan A; Zhang L; Irby K; Brock J
    J Manag Care Spec Pharm; 2019 Mar; 25(3):402-410. PubMed ID: 30816813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National burden of preventable adverse drug events associated with inpatient injectable medications: healthcare and medical professional liability costs.
    Lahue BJ; Pyenson B; Iwasaki K; Blumen HE; Forray S; Rothschild JM
    Am Health Drug Benefits; 2012 Nov; 5(7):1-10. PubMed ID: 24991335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.